Pfizer IncArticle highlights its ~7.2% dividend yield, 350 consecutive quarters of dividends, and pipeline of 96 programs including obesity drug berobenatide.
Enterprise Products Partners, Pfizer, and Verizon Communications are highlighted as stocks offering dividend yields of 5% or more. Enterprise Products Partners has a forward distribution yield of 6.1% and has increased its distribution for 27 consecutive years, supported by over 50,000 miles of pipelines and $5.3 billion in capital projects under construction. Pfizer yields around 7.2% and has paid a dividend for 350 consecutive quarters, with a pipeline of 96 programs and an experimental obesity drug, berobenatide, expected to launch in 2028. Verizon Communications offers a forward dividend yield of 6.2% and has raised its dividend for 19 straight years, with free cash flow growing to $3.8 billion in the first quarter and full-year 2026 free cash flow expected to reach at least $21.5 billion.
Pfizer IncArticle highlights its ~7.2% dividend yield, 350 consecutive quarters of dividends, and pipeline of 96 programs including obesity drug berobenatide.
Eli Lilly and Company
Enterprise Products Partners LPArticle highlights its 6.1% forward distribution yield, 27-year distribution growth streak, and $5.3B in capital projects, making it a recommended dividend stock.
Verizon Communications IncArticle highlights its 6.2% forward dividend yield, 19-year dividend growth streak, and growing free cash flow ($3.8B Q1, $21.5B expected FY2026).
NVIDIA Corporation